1. Home
  2. Clinical Topics
  3. FDA requires safety labeling changes for fluoroquinolones
Clinical TopicsDrugs and DevicesWeb Exclusives
fda safety labeling fluoroquinolones

FDA requires safety labeling changes for fluoroquinolones

Share

On July 10, the U.S. Food and Drug Administration (FDA) announced safety labeling changes for fluoroquinolones, including stronger warnings about risks of mental health disturbances and hypoglycemic coma.

Read more via FDA.gov.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts